On February 14, 2023 MENLO PARK, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT) reported it will report fourth quarter and full-year 2022 financial results and provide a corporate update on February 28, 2023 (Press release, Corcept Therapeutics, FEB 14, 2023, https://ir.corcept.com/news-releases/news-release-details/corcept-therapeutics-announce-fourth-quarter-and-full-year-2022 [SID1234627171]). The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information
To access the conference call, please dial 877-407-8029 from the United States or +1-201-689-8029 internationally.

A replay of the call will be available on the Investors / Events tab of www.corcept.com.